{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:31:48Z","timestamp":1772778708295,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004896","name":"Eisai Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.sleep.2023.07.023","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T09:00:57Z","timestamp":1690448457000},"page":"111-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Efficacy and safety of lemborexant in subjects previously treated with placebo for 6 months in a randomized phase 3 study"],"prefix":"10.1016","volume":"110","author":[{"given":"Jane","family":"Yardley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Pinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Perdomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Perlis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Moline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2023.07.023_bib1","article-title":"Why treat insomnia?","volume":"12","author":"Matteson-Rusby","year":"2010","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.sleep.2023.07.023_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/21501327211014084","article-title":"Why treat insomnia?","volume":"12","author":"Perlis","year":"2021","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.sleep.2023.07.023_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/M15-2175","article-title":"Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sleep.2023.07.023_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.sleep.2020.03.022","article-title":"Pharmacological interventions for the treatment of insomnia: quantitative comparison of drug efficacy","volume":"72","author":"Zheng","year":"2020","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2023.07.023_bib5","first-page":"925","article-title":"Effect of placebo conditions on polysomnographic parameters in primary insomnia: a meta-analysis","volume":"38","author":"Winkler","year":"2015","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.07.023_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12997","article-title":"Dynamic features of placebo effects addressing persistent insomnia disorder: a meta-analysis of placebo-controlled randomized clinical trials","volume":"29","author":"Jiang","year":"2020","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleep.2023.07.023_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.smrv.2005.05.001","article-title":"Placebo effects in primary insomnia","volume":"9","author":"Perlis","year":"2005","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2023.07.023_bib8","doi-asserted-by":"crossref","first-page":"zsz286","DOI":"10.1093\/sleep\/zsz286","article-title":"Quantitative analysis of the placebo response in pharmacotherapy of insomnia and its application in clinical trials","volume":"43","author":"Zheng","year":"2020","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.07.023_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/s1389-9457(02)00242-3","article-title":"A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials","volume":"4","author":"McCall","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2023.07.023_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa123","article-title":"Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2","volume":"43","author":"K\u00e4rpp\u00e4","year":"2020","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.07.023_bib11","unstructured":"ClinicalTrials.gov website. Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2). https:\/\/www.clinicaltrials.gov\/ProvidedDocs\/20\/NCT02952820\/Prot_002.pdf."},{"key":"10.1016\/j.sleep.2023.07.023_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.sleep.2021.01.048","article-title":"Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial","volume":"80","author":"Yardley","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2023.07.023_bib13","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"10.1016\/j.sleep.2023.07.023_bib14","series-title":"Manual for the Beck depression inventory-II","author":"Beck","year":"1996"},{"key":"10.1016\/j.sleep.2023.07.023_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1037\/0278-6133.20.2.112","article-title":"Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients","volume":"20","author":"Arnau","year":"2001","journal-title":"Health Psychol"},{"key":"10.1016\/j.sleep.2023.07.023_bib16","series-title":"Beck anxiety inventory manual","author":"Beck","year":"1993"},{"key":"10.1016\/j.sleep.2023.07.023_bib17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jpsychires.2011.03.011","article-title":"Should we be anxious when assessing anxiety using the Beck Anxiety Inventory in clinical insomnia patients?","volume":"45","author":"Carney","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.sleep.2023.07.023_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/sleep\/26.2.213","article-title":"Evidence for the validity of a sleep habits survey for adolescents","volume":"26","author":"Wolfson","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.07.023_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.sleep.2019.05.015","article-title":"Validity of two retrospective questionnaire versions of the Consensus Sleep Diary: the whole week and split week Self-Assessment of Sleep Surveys","volume":"63","author":"Dietch","year":"2019","journal-title":"Sleep Med"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723002666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723002666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:43:02Z","timestamp":1761406982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945723002666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":19,"alternative-id":["S1389945723002666"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2023.07.023","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of lemborexant in subjects previously treated with placebo for 6 months in a randomized phase 3 study","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2023.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}